Are you Dr. Kelly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Endocrinology
Philadelphia, PA 19104Phone+1 215-590-3174Fax+1 215-590-3053
Summary
- Dr. Andrea Kelly, MD is a pediatric endocrinologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, and Pennsylvania Hospital.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Endocrinology, 1998 - 2001
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1995 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
- PA State Medical License 1996 - 2026
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes Start of enrollment: 2005 Oct 01
- Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis Start of enrollment: 2008 Mar 01
- Down Syndrome Metabolic Health Study Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Glycemia and Insulin Secretion in Cystic Fibrosis Two Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO.Christine L Chan, Meghan Shirley Bezerra, Darko Stefanovski, Robert J Gallop, Rachel Walega
The Journal of Clinical Endocrinology and Metabolism. 2024-12-09 - Environmental Phenols and Growth in Infancy: The Infant Feeding and Early Development Study.Danielle R Stevens, Mandy Goldberg, Margaret Adgent, Helen B Chin, Donna D Baird
The Journal of Clinical Endocrinology and Metabolism. 2024-11-18 - The Type of Patient Training Does Not Impact Outcomes in the First 90 Days of Automated Insulin Delivery Use.Seema Meighan, Julia L Douvas, Andrew Rearson, Robert Squaresky, Andrea Kelly
Diabetes Technology & Therapeutics. 2024-10-01
Press Mentions
- Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study FindsJuly 21st, 2022
- Business Summary | Business | Herald Dispatch.comJuly 18th, 2021
- Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual MeetingNovember 9th, 2020